SCHEMBL29137205

SCHEMBL29137205

Cc1cccc(CN2CCN(c3cc(=O)n(C)c4ccc(Cl)nc34)CC2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
KDM4E B2RXH2 3/20 0.49
MAPT P10636 1/20 0.49
USP2 O75604 2/20 0.44
HTT P42858 1/20 0.43
DRD2 P14416 4/20 0.42
CYP3A4 P08684 2/20 0.42
DRD4 P21917 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
HPN P05981 1/20 0.42
CHRM2 P08172 1/20 0.42
ADRA2A P08913 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
CHRM1 P11229 1/20 0.42
ADRA2C P18825 1/20 0.42
CNR1 P21554 1/20 0.42
DRD1 P21728 1/20 0.42
SLC6A2 P23975 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29137184 0.90 DRD2 (0.40) ALDH1A1MAPTDRD2DRD4LMNA
SCHEMBL29137279 0.89 DRD2 (0.43) ALDH1A1KDM4EMAPTDRD2DRD4
SCHEMBL30616673 0.87 SIGMAR1 (0.51) ALDH1A1KDM4EMAPTDRD2DRD4
SCHEMBL29137283 0.85 DRD4 (0.38) ALDH1A1MAPTDRD4KCNH2HTR1A
SCHEMBL30616751 0.84 DRD4 (0.42) ALDH1A1MAPTUSP2HTTCYP3A4
SCHEMBL30616711 0.84 GRM2 (0.41) ALDH1A1KDM4EMAPTDRD2DRD4
SCHEMBL30616757 0.83 SIGMAR1 (0.43) MAPTDRD4SLC6A4KCNH2HTR1A
SCHEMBL29137229 0.83 TRPC5 (0.48) ALDH1A1KDM4EMAPTCNR1HTR1A
SCHEMBL30616679 0.83 GRM2 (0.45) ALDH1A1KDM4EMAPTHTTDRD4
SCHEMBL30616754 0.80 MEN1 (0.46) ALDH1A1KDM4EMAPTDRD4SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112585139-B Naphthyridinone compounds as T cell activators 百时美施贵宝公司 2023-12-01 CN disclosed